Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3774 entries
Sorted by: Best Match Show Resources per page
Retraction--autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy.

Cell

Hood L, Urban JL, Horvath SJ.
PMID: 1988145
Cell. 1991 Jan 25;64(2):231-2. doi: 10.1016/0092-8674(91)90634-b.

No abstract available.

Cite
Hood L, Urban JL, Horvath SJ. Retraction--autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy. Cell. 1991;64(2):231-2doi: 10.1016/0092-8674(91)90634-b.
Hood, L., Urban, J. L., & Horvath, S. J. (1991). Retraction--autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy. Cell, 64(2), 231-2. https://doi.org/10.1016/0092-8674(91)90634-b
Hood, L, et al. "Retraction--autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy." Cell vol. 64,2 (1991): 231-2. doi: https://doi.org/10.1016/0092-8674(91)90634-b
Hood L, Urban JL, Horvath SJ. Retraction--autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide-based therapy. Cell. 1991 Jan 25;64(2):231-2. doi: 10.1016/0092-8674(91)90634-b. PMID: 1988145.
Copy Download .nbib Format: NLM
Molecular serum markers of liver fibrosis.

Biomarker insights

Liu T, Wang X, Karsdal MA, Leeming DJ, Genovese F.
PMID: 22872786
Biomark Insights. 2012;7:105-17. doi: 10.4137/BMI.S10009. Epub 2012 Jul 23.

Fibrosis is a hallmark histologic event of chronic liver diseases and is characterized by the excessive accumulation and reorganization of the extracellular matrix (ECM). The gold standard for assessment of fibrosis is liver biopsy. As this procedure has various...

Cite
Liu T, Wang X, Karsdal MA, et al. Molecular serum markers of liver fibrosis. Biomark Insights. 2012;7:105-17doi: 10.4137/BMI.S10009.
Liu, T., Wang, X., Karsdal, M. A., Leeming, D. J., & Genovese, F. (2012). Molecular serum markers of liver fibrosis. Biomarker insights, 7105-17. https://doi.org/10.4137/BMI.S10009
Liu, Tianhui, et al. "Molecular serum markers of liver fibrosis." Biomarker insights vol. 7 (2012): 105-17. doi: https://doi.org/10.4137/BMI.S10009
Liu T, Wang X, Karsdal MA, Leeming DJ, Genovese F. Molecular serum markers of liver fibrosis. Biomark Insights. 2012;7:105-17. doi: 10.4137/BMI.S10009. Epub 2012 Jul 23. PMID: 22872786; PMCID: PMC3412619.
Copy Download .nbib Format: NLM
A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts.

Autoimmune diseases

Vaughan K, Kim Y, Sette A.
PMID: 23243503
Autoimmune Dis. 2012;2012:403915. doi: 10.1155/2012/403915. Epub 2012 Dec 02.

Here we analyzed the molecular targets associated with myasthenia gravis (MG) immune responses, enabled by an immune epitope database (IEDB) inventory of approximately 600 MG-related epitopes derived from 175 references. The vast majority of epitopes were derived from the...

Cite
Vaughan K, Kim Y, Sette A. A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts. Autoimmune Dis. 2012;2012:403915doi: 10.1155/2012/403915.
Vaughan, K., Kim, Y., & Sette, A. (2012). A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts. Autoimmune diseases, 2012403915. https://doi.org/10.1155/2012/403915
Vaughan, Kerrie, et al. "A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts." Autoimmune diseases vol. 2012 (2012): 403915. doi: https://doi.org/10.1155/2012/403915
Vaughan K, Kim Y, Sette A. A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts. Autoimmune Dis. 2012;2012:403915. doi: 10.1155/2012/403915. Epub 2012 Dec 02. PMID: 23243503; PMCID: PMC3518085.
Copy Download .nbib Format: NLM
Reactive oxygen species in organ-specific autoimmunity.

Auto- immunity highlights

Di Dalmazi G, Hirshberg J, Lyle D, Freij JB, Caturegli P.
PMID: 27491295
Auto Immun Highlights. 2016 Dec;7(1):11. doi: 10.1007/s13317-016-0083-0. Epub 2016 Aug 04.

Reactive oxygen species (ROS) have been extensively studied in the induction of inflammation and tissue damage, especially as it relates to aging. In more recent years, ROS have been implicated in the pathogenesis of autoimmune diseases. Here, ROS accumulation...

Cite
Di Dalmazi G, Hirshberg J, Lyle D, et al. Reactive oxygen species in organ-specific autoimmunity. Auto Immun Highlights. 2016;7(1):11doi: 10.1007/s13317-016-0083-0.
Di Dalmazi, G., Hirshberg, J., Lyle, D., Freij, J. B., & Caturegli, P. (2016). Reactive oxygen species in organ-specific autoimmunity. Auto- immunity highlights, 7(1), 11. https://doi.org/10.1007/s13317-016-0083-0
Di Dalmazi, Giulia, et al. "Reactive oxygen species in organ-specific autoimmunity." Auto- immunity highlights vol. 7,1 (2016): 11. doi: https://doi.org/10.1007/s13317-016-0083-0
Di Dalmazi G, Hirshberg J, Lyle D, Freij JB, Caturegli P. Reactive oxygen species in organ-specific autoimmunity. Auto Immun Highlights. 2016 Dec;7(1):11. doi: 10.1007/s13317-016-0083-0. Epub 2016 Aug 04. PMID: 27491295; PMCID: PMC4974204.
Copy Download .nbib Format: NLM
Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.

Frontiers in immunology

Peng B, Peng N, Zhang Y, Zhang F, Li X, Chang H, Fang F, Wang F, Lu F, Chen Z.
PMID: 28912784
Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017.

The 2009 H1N1 influenza (Pdm09) pandemic has been referred to as the first influenza pandemic of the twenty-first century. There is a marked difference in antigenicity between the pandemic H1N1 virus and past seasonal H1N1 viruses, which allowed the...

Cite
Peng B, Peng N, Zhang Y, et al. Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Front Immunol. 2017;8:1070doi: 10.3389/fimmu.2017.01070.
Peng, B., Peng, N., Zhang, Y., Zhang, F., Li, X., Chang, H., Fang, F., Wang, F., Lu, F., & Chen, Z. (2017). Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Frontiers in immunology, 81070. https://doi.org/10.3389/fimmu.2017.01070
Peng, Bo, et al. "Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin." Frontiers in immunology vol. 8 (2017): 1070. doi: https://doi.org/10.3389/fimmu.2017.01070
Peng B, Peng N, Zhang Y, Zhang F, Li X, Chang H, Fang F, Wang F, Lu F, Chen Z. Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017. PMID: 28912784; PMCID: PMC5583165.
Copy Download .nbib Format: NLM
Classification of self-assembling protein nanoparticle architectures for applications in vaccine design.

Royal Society open science

Indelicato G, Burkhard P, Twarock R.
PMID: 28484626
R Soc Open Sci. 2017 Apr 26;4(4):161092. doi: 10.1098/rsos.161092. eCollection 2017 Apr.

We introduce here a mathematical procedure for the structural classification of a specific class of self-assembling protein nanoparticles (SAPNs) that are used as a platform for repetitive antigen display systems. These SAPNs have distinctive geometries as a consequence of...

Cite
Indelicato G, Burkhard P, Twarock R. Classification of self-assembling protein nanoparticle architectures for applications in vaccine design. R Soc Open Sci. 2017;4(4):161092doi: 10.1098/rsos.161092.
Indelicato, G., Burkhard, P., & Twarock, R. (2017). Classification of self-assembling protein nanoparticle architectures for applications in vaccine design. Royal Society open science, 4(4), 161092. https://doi.org/10.1098/rsos.161092
Indelicato, G, et al. "Classification of self-assembling protein nanoparticle architectures for applications in vaccine design." Royal Society open science vol. 4,4 (2017): 161092. doi: https://doi.org/10.1098/rsos.161092
Indelicato G, Burkhard P, Twarock R. Classification of self-assembling protein nanoparticle architectures for applications in vaccine design. R Soc Open Sci. 2017 Apr 26;4(4):161092. doi: 10.1098/rsos.161092. eCollection 2017 Apr. PMID: 28484626; PMCID: PMC5414263.
Copy Download .nbib Format: NLM
KIR repertory in patients with hematopoietic diseases and healthy family members.

BMC hematology

Sugioka DK, Gonçalves CE, Bicalho MD.
PMID: 27708784
BMC Hematol. 2016 Sep 29;16:25. doi: 10.1186/s12878-016-0064-6. eCollection 2016.

BACKGROUND: Since the discovery of specific histocompatibility, literature has associated genes involved in the immune response, like the Human Leucocyte Antigen (HLA), with a better prognosis in transplantation. However, other non-HLA genes may also influence the immune process, such...

Cite
Sugioka DK, Gonçalves CE, Bicalho MD. KIR repertory in patients with hematopoietic diseases and healthy family members. BMC Hematol. 2016;16:25doi: 10.1186/s12878-016-0064-6.
Sugioka, D. K., Gonçalves, C. E., & Bicalho, M. D. (2016). KIR repertory in patients with hematopoietic diseases and healthy family members. BMC hematology, 1625. https://doi.org/10.1186/s12878-016-0064-6
Sugioka, Daniele Kazue, et al. "KIR repertory in patients with hematopoietic diseases and healthy family members." BMC hematology vol. 16 (2016): 25. doi: https://doi.org/10.1186/s12878-016-0064-6
Sugioka DK, Gonçalves CE, Bicalho MD. KIR repertory in patients with hematopoietic diseases and healthy family members. BMC Hematol. 2016 Sep 29;16:25. doi: 10.1186/s12878-016-0064-6. eCollection 2016. PMID: 27708784; PMCID: PMC5041293.
Copy Download .nbib Format: NLM
Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

JCI insight

Granoff DM, Giuntini S, Gowans FA, Lujan E, Sharkey K, Beernink PT.
PMID: 27668287
JCI Insight. 2016 Sep 08;1(14):e88907. doi: 10.1172/jci.insight.88907.

Meningococcal factor H-binding protein (FHbp) is an antigen in 2 serogroup B meningococcal vaccines. FHbp specifically binds human and some nonhuman primate complement FH. To investigate the effect of binding of FH to FHbp on protective antibody responses, we...

Cite
Granoff DM, Giuntini S, Gowans FA, et al. Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI Insight. 2016;1(14):e88907doi: 10.1172/jci.insight.88907.
Granoff, D. M., Giuntini, S., Gowans, F. A., Lujan, E., Sharkey, K., & Beernink, P. T. (2016). Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI insight, 1(14), e88907. https://doi.org/10.1172/jci.insight.88907
Granoff, Dan M, et al. "Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding." JCI insight vol. 1,14 (2016): e88907. doi: https://doi.org/10.1172/jci.insight.88907
Granoff DM, Giuntini S, Gowans FA, Lujan E, Sharkey K, Beernink PT. Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding. JCI Insight. 2016 Sep 08;1(14):e88907. doi: 10.1172/jci.insight.88907. PMID: 27668287; PMCID: PMC5033880.
Copy Download .nbib Format: NLM
Identification of glypican-3-derived long peptides activating both CD8.

Oncoimmunology

Sayem MA, Tomita Y, Yuno A, Hirayama M, Irie A, Tsukamoto H, Senju S, Yuba E, Yoshikawa T, Kono K, Nakatsura T, Nishimura Y.
PMID: 26942076
Oncoimmunology. 2015 Aug 31;5(1):e1062209. doi: 10.1080/2162402X.2015.1062209. eCollection 2016.

In a recent phase I clinical trial, a vaccine consisting of glypican-3 (GPC3)-derived CTL epitopes was found to be safe and induced measurable immune and clinical responses in patients with hepatocellular carcinoma (HCC). The aim of this study was...

Cite
Sayem MA, Tomita Y, Yuno A, et al. Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology. 2015;5(1):e1062209doi: 10.1080/2162402X.2015.1062209.
Sayem, M. A., Tomita, Y., Yuno, A., Hirayama, M., Irie, A., Tsukamoto, H., Senju, S., Yuba, E., Yoshikawa, T., Kono, K., Nakatsura, T., & Nishimura, Y. (2016). Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology, 5(1), e1062209. https://doi.org/10.1080/2162402X.2015.1062209
Sayem, Mohammad A, et al. "Identification of glypican-3-derived long peptides activating both CD8." Oncoimmunology vol. 5,1 (2016): e1062209. doi: https://doi.org/10.1080/2162402X.2015.1062209
Sayem MA, Tomita Y, Yuno A, Hirayama M, Irie A, Tsukamoto H, Senju S, Yuba E, Yoshikawa T, Kono K, Nakatsura T, Nishimura Y. Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology. 2015 Aug 31;5(1):e1062209. doi: 10.1080/2162402X.2015.1062209. eCollection 2016. PMID: 26942076; PMCID: PMC4760284.
Copy Download .nbib Format: NLM
Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus.

Experimental and therapeutic medicine

Wang X, Sun Q, Ye Z, Hua Y, Shao N, Du Y, Zhang Q, Wan C.
PMID: 27703505
Exp Ther Med. 2016 Oct;12(4):2439-2446. doi: 10.3892/etm.2016.3636. Epub 2016 Aug 31.

An avian-origin influenza H7N9 virus epidemic occurred in China in 2013-2014, in which >422 infected people suffered from pneumonia, respiratory distress syndrome and septic shock. H7N9 viruses belong to the H7 subtype of avian-origin influenza viruses (AIV-H7). Hemagglutinin (HA)...

Cite
Wang X, Sun Q, Ye Z, et al. Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus. Exp Ther Med. 2016;12(4):2439-2446doi: 10.3892/etm.2016.3636.
Wang, X., Sun, Q., Ye, Z., Hua, Y., Shao, N., Du, Y., Zhang, Q., & Wan, C. (2016). Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus. Experimental and therapeutic medicine, 12(4), 2439-2446. https://doi.org/10.3892/etm.2016.3636
Wang, Xiangyu, et al. "Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus." Experimental and therapeutic medicine vol. 12,4 (2016): 2439-2446. doi: https://doi.org/10.3892/etm.2016.3636
Wang X, Sun Q, Ye Z, Hua Y, Shao N, Du Y, Zhang Q, Wan C. Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus. Exp Ther Med. 2016 Oct;12(4):2439-2446. doi: 10.3892/etm.2016.3636. Epub 2016 Aug 31. PMID: 27703505; PMCID: PMC5038878.
Copy Download .nbib Format: NLM
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections.

JCI insight

Kam YW, Lee CY, Teo TH, Howland SW, Amrun SN, Lum FM, See P, Kng NQ, Huber RG, Xu MH, Tan HL, Choo A, Maurer-Stroh S, Ginhoux F, Fink K, Wang CI, Ng LF, Rénia L.
PMID: 28422757
JCI Insight. 2017 Apr 20;2(8). doi: 10.1172/jci.insight.92428. eCollection 2017 Apr 20.

Zika virus (ZIKV) infections have been linked with neurological complications and congenital Zika syndrome. Given the high level of homology between ZIKV and the related flavivirus dengue virus (DENV), we investigated the level of cross-reactivity with ZIKV using a...

Cite
Kam YW, Lee CY, Teo TH, et al. Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight. 2017;2(8)doi: 10.1172/jci.insight.92428.
Kam, Y. W., Lee, C. Y., Teo, T. H., Howland, S. W., Amrun, S. N., Lum, F. M., See, P., Kng, N. Q., Huber, R. G., Xu, M. H., Tan, H. L., Choo, A., Maurer-Stroh, S., Ginhoux, F., Fink, K., Wang, C. I., Ng, L. F., & Rénia, L. (2017). Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI insight, 2(8), . https://doi.org/10.1172/jci.insight.92428
Kam, Yiu-Wing, et al. "Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections." JCI insight vol. 2,8 (2017). doi: https://doi.org/10.1172/jci.insight.92428
Kam YW, Lee CY, Teo TH, Howland SW, Amrun SN, Lum FM, See P, Kng NQ, Huber RG, Xu MH, Tan HL, Choo A, Maurer-Stroh S, Ginhoux F, Fink K, Wang CI, Ng LF, Rénia L. Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight. 2017 Apr 20;2(8). doi: 10.1172/jci.insight.92428. eCollection 2017 Apr 20. PMID: 28422757; PMCID: PMC5396524.
Copy Download .nbib Format: NLM
Mycobacterium avium ss. paratuberculosis Zoonosis - The Hundred Year War - Beyond Crohn's Disease.

Frontiers in immunology

Sechi LA, Dow CT.
PMID: 25788897
Front Immunol. 2015 Mar 04;6:96. doi: 10.3389/fimmu.2015.00096. eCollection 2015.

The factitive role of Mycobacterium avium ss. paratuberculosis (MAP) in Crohn's disease has been debated for more than a century. The controversy is due to the fact that Crohn's disease is so similar to a disease of MAP-infected ruminant...

Cite
Sechi LA, Dow CT. Mycobacterium avium ss. paratuberculosis Zoonosis - The Hundred Year War - Beyond Crohn's Disease. Front Immunol. 2015;6:96doi: 10.3389/fimmu.2015.00096.
Sechi, L. A., & Dow, C. T. (2015). Mycobacterium avium ss. paratuberculosis Zoonosis - The Hundred Year War - Beyond Crohn's Disease. Frontiers in immunology, 696. https://doi.org/10.3389/fimmu.2015.00096
Sechi, Leonardo A, and Dow, Coad Thomas. "Mycobacterium avium ss. paratuberculosis Zoonosis - The Hundred Year War - Beyond Crohn's Disease." Frontiers in immunology vol. 6 (2015): 96. doi: https://doi.org/10.3389/fimmu.2015.00096
Sechi LA, Dow CT. Mycobacterium avium ss. paratuberculosis Zoonosis - The Hundred Year War - Beyond Crohn's Disease. Front Immunol. 2015 Mar 04;6:96. doi: 10.3389/fimmu.2015.00096. eCollection 2015. PMID: 25788897; PMCID: PMC4349160.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3774 entries